Quest Diagnostics Inc Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
Quest Diagnostics Inc (DGX) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of -$5.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-04-28.
Discontinued › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2023-04-28
- Quest Diagnostics Inc effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2023-03-31 was -$5.00M.
- Quest Diagnostics Inc effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2022-06-30 was $4.00M, a 20.00% decline year-over-year.
- Quest Diagnostics Inc effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2022-03-31 was -$5.00M.
- Quest Diagnostics Inc effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2021-09-30 was -$6.00M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month as first filed | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month as first filed |
|---|---|---|---|---|---|
| 2023-03-31 | -$5.00M 10-Q · filed 2023-04-28 | ||||
| 2022-09-30 | $10.00M 10-Q · filed 2022-10-21 | ||||
| 2022-06-30 | $4.00M 10-Q · filed 2022-07-22 | $9.00M 10-Q · filed 2022-07-22 | |||
| 2022-03-31 | -$5.00M 10-Q · filed 2023-04-28 | ||||
| 2021-09-30 | -$6.00M 10-Q · filed 2021-10-22 | $15.00M 10-Q · filed 2022-10-21 | -$15.00M 10-Q · filed 2021-10-22 | ||
| 2021-06-30 | $5.00M 10-Q · filed 2022-07-22 | $9.00M 10-Q · filed 2022-07-22 | |||
| 2020-09-30 | -$3.00M 10-Q · filed 2021-10-22 | $3.00M 10-Q · filed 2020-10-23 | -$15.00M 10-Q · filed 2021-10-22 | $15.00M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $4.00M 10-Q · filed 2021-07-23 | $12.00M 10-Q · filed 2021-07-23 | |||
| 2020-03-31 | $8.00M 10-Q · filed 2020-05-04 | ||||
| 2019-09-30 | $3.00M 10-Q · filed 2020-10-23 | $11.00M 10-Q · filed 2020-10-23 | |||
| 2019-06-30 | $5.00M 10-Q · filed 2020-07-24 | $8.00M 10-Q · filed 2020-07-24 | |||
| 2019-03-31 | $3.00M 10-Q · filed 2020-05-04 | ||||
| 2018-09-30 | $4.00M 10-Q · filed 2019-10-23 | $17.00M 10-Q · filed 2019-10-23 | |||
| 2018-06-30 | $5.00M 10-Q · filed 2019-07-24 | $13.00M 10-Q · filed 2019-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |